CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company
Tessera Defense & Homeland Security Inc.
Sign in to watch- Ticker
- HLSQ
- Exchange
- NYSE
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823364020
- Phone
- 972 545610935
- Business address
- 850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
- Former names
- BiomX Inc., Chardan Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-14 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award | +126,748 | 126,748 | ||
| 2025-04-14 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award · Common Stock Options - right to Buy | −380,500 | 380,500 | ||
| 2025-04-14 | Blum Susan Director | Grant or award · Common Stock Options - right to Buy | −17,600 | 17,600 | ||
| 2025-04-14 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +17,600 | 17,600 | ||
| 2025-02-27 | Flynn James E Director | Option exercise | +353,249 | $0.93 | $329K | 1,247,054 |
| 2025-02-27 | Flynn James E Director | Option exercise | +353,249 | $0.93 | $329K | 1,247,054 |
| 2025-02-27 | Flynn James E Director | Option exercise · Warrants | −1,611,863 | 405,637 | ||
| 2025-02-27 | Flynn James E Director | Option exercise · Warrants | −1,611,863 | 405,637 | ||
| 2025-02-27 | Flynn James E Director | Grant or award · Warrants | +1,258,614 | 1,258,614 | ||
| 2025-02-27 | Flynn James E Director | Grant or award · Warrants | +1,258,614 | 1,258,614 | ||
| 2024-09-16 | Bassan Merav Chief Development Officer | Grant or award | +31,749 | 31,749 | ||
| 2024-09-16 | Solomon Jonathan Eitan Chief Executive Officer | Grant or award | +50,556 | 53,056 | ||
| 2024-09-16 | Oron Assaf Chief Business Officer | Grant or award | +25,804 | 25,804 | ||
| 2024-07-15 | Flynn James E Director | Option exercise | +5,883,000 | 8,938,049 | ||
| 2024-07-15 | Flynn James E Director | Option exercise | +5,883,000 | 8,938,049 | ||
| 2024-07-15 | Flynn James E Director | Option exercise · Series X Non-Voting Convertible Preferred Stock | −5,883 | 47,957 | ||
| 2024-07-15 | Flynn James E Director | Option exercise · Series X Non-Voting Convertible Preferred Stock | −5,883 | 47,957 | ||
| 2024-07-11 | Blum Susan Director | Grant or award · Common Stock Options - Right to Buy | +264,000 | 264,000 | ||
| 2024-07-11 | Greig Russell Director | Grant or award · Common Stock Options - Right to Buy | +352,000 | 352,000 | ||
| 2024-07-11 | Bassan Merav Chief Development Officer | Grant or award · Common Stock Options - Right to Buy | +950,000 | 950,000 |
Page 3 of 12 · 240 trades